tradingkey.logo

Teleflex Inc

TFX

116.955USD

+1.065+0.92%
交易中 美東報價延遲15分鐘
5.17B總市值
34.60本益比TTM

Teleflex Inc

116.955

+1.065+0.92%
關於 Teleflex Inc 公司
Teleflex Incorporated 是一家全球醫療技術產品供應商。該公司主要設計、開發、製造和供應一次性醫療設備,供醫院和醫療保健提供商用於重症監護和外科應用中的常見診斷和治療程序。該公司有四個部門:美洲、EMEA(歐洲、中東和非洲)、亞洲(亞太地區)和 OEM(原始設備製造商和開發服務)。OEM 部門爲其他醫療設備製造商設計、製造和供應設備和儀器。其 OEM 部門包括 TFX Medical OEM、TFX OEM、Deknatel 和 HPC Medical 品牌,提供定製擠壓件、微直徑薄膜鑄造管、診斷和介入導管、球囊和球囊導管、薄膜絕緣細線、塗層芯軸線、導體、護套/擴張器導入器等。其其他品牌包括 Arrow、LMA、Pilling、QuikClot、Rusch、UroLift、Weck 和 Barrigel。
公司簡介
公司代碼TFX
公司名稱Teleflex Inc
上市日期Mar 17, 1980
CEOMr. Liam J. Kelly
員工數量14100
證券類型Ordinary Share
年結日Mar 17
公司地址550 E Swedesford Rd
城市WAYNE
上市交易所NYSE Consolidated
國家United States of America
郵編19087
電話16102256800
網址https://www.teleflex.com/usa/en/#
公司代碼TFX
上市日期Mar 17, 1980
CEOMr. Liam J. Kelly
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
49.49K
+19.61%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
9.22K
+12.86%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
5.54K
+23.40%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.16K
+25.60%
Mr. John C. Heinmiller
Mr. John C. Heinmiller
Independent Director
Independent Director
4.39K
+31.47%
Ms. Neena M. Patil, J.D.
Ms. Neena M. Patil, J.D.
Independent Director
Independent Director
1.98K
+113.50%
Dr. Jaewon Ryu, M.D., J.D.
Dr. Jaewon Ryu, M.D., J.D.
Independent Director
Independent Director
1.58K
+199.43%
Mr. John R. Deren
Mr. John R. Deren
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
49.49K
+19.61%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
9.22K
+12.86%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
5.54K
+23.40%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.16K
+25.60%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Vascular access
182.37M
26.03%
Interventional
137.56M
19.63%
Surgical
105.78M
15.10%
Anesthesia
86.59M
12.36%
Interventional urology
70.97M
10.13%
Other
117.40M
16.75%
地區USD
名稱
營收
佔比
Americas
475.72M
67.90%
EMEA
151.16M
21.57%
Asia Pacific
73.79M
10.53%
業務
地區
業務USD
名稱
營收
佔比
Vascular access
182.37M
26.03%
Interventional
137.56M
19.63%
Surgical
105.78M
15.10%
Anesthesia
86.59M
12.36%
Interventional urology
70.97M
10.13%
Other
117.40M
16.75%
股東統計
更新時間: 7月26日 週六
更新時間: 7月26日 週六
持股股東
股東類型
持股股東
持股股東
佔比
T. Rowe Price Investment Management, Inc.
14.07%
BlackRock Institutional Trust Company, N.A.
12.12%
The Vanguard Group, Inc.
11.47%
Janus Henderson Investors
9.79%
UBS Financial Services, Inc.
7.50%
Other
45.06%
持股股東
持股股東
佔比
T. Rowe Price Investment Management, Inc.
14.07%
BlackRock Institutional Trust Company, N.A.
12.12%
The Vanguard Group, Inc.
11.47%
Janus Henderson Investors
9.79%
UBS Financial Services, Inc.
7.50%
Other
45.06%
股東類型
持股股東
佔比
Investment Advisor
67.05%
Investment Advisor/Hedge Fund
28.93%
Hedge Fund
7.40%
Research Firm
2.30%
Pension Fund
1.73%
Sovereign Wealth Fund
1.38%
Bank and Trust
0.40%
Individual Investor
0.33%
Family Office
0.09%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
1156
48.39M
109.50%
-826.33K
2025Q1
1189
48.85M
110.52%
-721.30K
2024Q4
1180
47.47M
102.37%
-260.40K
2024Q3
1150
46.34M
98.36%
-1.83M
2024Q2
1147
46.98M
99.75%
-268.09K
2024Q1
1153
46.02M
97.70%
-1.89M
2023Q4
1170
46.05M
97.91%
-2.57M
2023Q3
1173
45.95M
97.77%
-3.19M
2023Q2
1201
46.87M
99.79%
-2.79M
2023Q1
1212
46.93M
99.93%
-1.70M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
T. Rowe Price Investment Management, Inc.
6.22M
14.07%
+43.64K
+0.71%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.36M
12.12%
+2.71M
+102.18%
Mar 31, 2025
The Vanguard Group, Inc.
5.07M
11.47%
-456.07K
-8.26%
Mar 31, 2025
Janus Henderson Investors
4.33M
9.79%
-933.48K
-17.75%
Mar 31, 2025
UBS Financial Services, Inc.
3.31M
7.5%
+3.09M
+1413.63%
Mar 31, 2025
Atlanta Capital Management Company, L.L.C.
2.78M
6.29%
+73.14K
+2.70%
Mar 31, 2025
State Street Global Advisors (US)
1.53M
3.46%
-531.22K
-25.79%
Mar 31, 2025
Cooke & Bieler, L.P.
1.06M
2.39%
-21.03K
-1.95%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.02M
2.31%
-119.68K
-10.51%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
867.86K
1.96%
+355.72K
+69.46%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco S&P SmallCap Health Care ETF
3.74%
SPDR S&P Health Care Equipment ETF
1.76%
First Trust Indxx Medical Devices ETF
1.67%
Distillate Small/Mid Cash Flow ETF
0.99%
SPDR S&P 600 Small Cap Value ETF
0.82%
iShares S&P Small-Cap 600 Value ETF
0.82%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.75%
VictoryShares Small Cap Free Cash Flow ETF
0.68%
iShares U.S. Medical Devices ETF
0.59%
SPDR S&P SmallCap 600 ESG ETF
0.55%
查看更多
Invesco S&P SmallCap Health Care ETF
佔比3.74%
SPDR S&P Health Care Equipment ETF
佔比1.76%
First Trust Indxx Medical Devices ETF
佔比1.67%
Distillate Small/Mid Cash Flow ETF
佔比0.99%
SPDR S&P 600 Small Cap Value ETF
佔比0.82%
iShares S&P Small-Cap 600 Value ETF
佔比0.82%
iShares MSCI USA Small-Cap Min Vol Factor ETF
佔比0.75%
VictoryShares Small Cap Free Cash Flow ETF
佔比0.68%
iShares U.S. Medical Devices ETF
佔比0.59%
SPDR S&P SmallCap 600 ESG ETF
佔比0.55%
分紅派息
近5年累計派現 318.10M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Feb 27, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 17, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 17, 2025
Mar 07, 2025
Oct 31, 2024
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 16, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Dec 16, 2024
Nov 15, 2024
Aug 01, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 16, 2024 going ex on Aug 15, 2024
Aug 15, 2024
Sep 16, 2024
Aug 15, 2024
May 06, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 14, 2024 going ex on May 14, 2024
May 15, 2024
Jun 14, 2024
May 14, 2024
Feb 22, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 02, 2023
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Dec 15, 2023
Nov 14, 2023
Aug 03, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 15, 2023
Aug 14, 2023
May 08, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 15, 2023 going ex on May 12, 2023
May 15, 2023
Jun 15, 2023
May 12, 2023
Feb 23, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2023 going ex on Mar 02, 2023
Mar 03, 2023
Mar 15, 2023
Mar 02, 2023
Oct 27, 2022
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2022 going ex on Nov 14, 2022
Nov 15, 2022
Dec 15, 2022
Nov 14, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI